The mesenchymal stem cells global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Mesenchymal Stem Cells Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size -
The
mesenchymal stem cells market size has grown rapidly in recent years.
It will grow from $3.00 billion in 2023 to $3.38 billion in 2024 at a
compound annual growth rate (CAGR) of 12.5%. The growth in the historic
period can be attributed to the regenerative medicine paradigm shift,
collaborative research efforts, increased public awareness of stem cell
research and patient advocacy, international collaboration, and
standardization initiatives.
The mesenchymal stem cells market size is expected to see rapid growth in the next few years. It will grow to $5.45 billion in 2028 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to continued advancements in genetic engineering technologies, the adoption of personalized medicine approaches, the integration of artificial intelligence (AI) and data analytics, advances in biomaterials science and 3D bioprinting technologies, the development of microfluidic devices and organ-on-a-chip models, the adoption of next-generation manufacturing technologies. Major trends in the forecast period include bioprinting and tissue engineering, gene editing, clinical application expansion, combination therapies, and MSC-derived extracellular vesicles (EVs).
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/mesenchymal-stem-cells-global-market-report
Scope Of Mesenchymal Stem Cells Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Mesenchymal Stem Cells Market Overview
Market Drivers -
The
growing awareness regarding regenerative medicine is expected to propel
the growth of the mesenchymal stem cells (MSC) market going forward.
Regenerative medicine is an emerging interdisciplinary field that
focuses on the repair, replacement, or regeneration of cells, tissues,
or organs to restore impaired function resulting from any cause,
including congenital defects, disease, trauma, and aging. Regenerative
medicine is increasing due to several key factors, such as growing
clinical trials, the growing incidence of chronic conditions,
age-related conditions, and personalized medicine. Mesenchymal stem
cells (MSCs) offer significant potential in regenerative medicine due to
their ability to differentiate into multiple cell types, modulate
immune responses, and promote tissue repair and regeneration across a
wide range of medical conditions. For instance, in August 2023,
according to a report by the Alliance for Regenerative Medicine, a
US-based non-profit organization, there were 2,760 cells, gene, and
tissue-engineering therapeutic developers worldwide in Q1 2023, up 101%
since 1,369 in Q1 2022. Moreover, financing for regenerative medicine
and advanced therapies in 2021 MSCl (mesenchymal stromal cell-like)
reached $22.7 billion, compared to $19.9 billion in 2020. Therefore,
growing awareness regarding regenerative medicine is driving the growth
of the mesenchymal stem cell (MSC) market.
Market Trends -
Major
companies operating in the mesenchymal stem cells (MSCs) market are
adopting innovative technologies, such as GMP-compliant isolation, to
strengthen their position in the market. GMP (Good Manufacturing
Practice)-compliant isolation refers to the process of isolating cells,
including mesenchymal stem cells (MSCs), according to GMP regulations to
ensure consistent production and control of product quality. For
instance, in July 2023, PromoCell, a Germany-based biotechnology
company, announced the launch of PromoExQ MSC Growth Medium XF, a serum-
and xeno-free medium designed for the expansion of human mesenchymal
stem cells (MSCs) in a Good Manufacturing Practice (GMP)-regulated
environment. This medium is manufactured under the highest quality
standards and is certified by the EXCiPACT GMP certification scheme,
ensuring consistent growth and maintenance of MSCs from various sources
such as bone marrow, umbilical cord matrix, and adipose tissue.
The mesenchymal stem cells market covered in this report is segmented –
1) By Type: Autologous, Allogeneic
2) By Product Type: Cells And Cell Lines, Kits, Media And Reagents, Other Product Types
3) By Workflow Type: Cell Sourcing And Isolation, Culture And Cryopreservation, Differentiation, Characterization
4)
By Indication : Bone And Cartilage Repair, Cardiovascular Diseases,
Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD,
Other Indications
5) By Application: Disease Modeling, Drug
Development And Discovery, Stem Cell Banking, Tissue Engineering,
Toxicology Studies, Other Applications
Get an inside scoop of the mesenchymal stem cells market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16116&type=smp
Regional Insights -
North
America was the largest region in the mesenchymal stem cells market in
2023. Asia-Pacific is expected to be the fastest-growing region in the
forecast period. The regions covered in the mesenchymal stem cells
market report are Asia-Pacific, Western Europe, Eastern Europe, North
America, South America, Middle East, Africa.
Key Companies -
Major
companies operating in the mesenchymal stem cells market are Thermo
Fischer Scientific Inc., Danaher Corporation, Merck KgaA, Becton,
Dickinson, and Company, Fujifilm Holdings Corporation, Corning Inc.,
Daiichi Sankyo, Lonza Group, Terumo Corporation, Sartorius AG, Getinge
AB, Bio-Rad Laboratories, Eppendorf AG, Bio-Techne Corporation, STEMCELL
Technologies Inc., Miltenyi Biotec GmBH, Takara Bio Group,
Organogenesis Holdings Inc., Vericel Corporation, HiMedia Laboratories,
PromoCell GmbH, CellGenix GmBH, Anterogen Co. Ltd., Pluristem
Therapeutics Inc., American Cryostem Corporation
Table of Contents
1. Executive Summary
2. Mesenchymal Stem Cells Market Report Structure
3. Mesenchymal Stem Cells Market Trends And Strategies
4. Mesenchymal Stem Cells Market – Macro Economic Scenario
5. Mesenchymal Stem Cells Market Size And Growth
…..
27. Mesenchymal Stem Cells Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment